A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

SLE

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Renji Hospital Shanghai Jiaotong University School of Medical, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Sheng Chen, Ph.D) · 13917556052@139.com · 13917556052
Contact: Principal Investigator (Sheng Chen, Ph.D.)

Study leads

Sheng Chen, Ph.D
Principal Investigator
Renji Hospital Shanghai Jiaotong University School of Medical

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MB-CART19.1 in Refractory SLE

SLE - Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Erlangen, Germany · Magdeburg, Germany

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Periodontal Disease · Periodontitis · CKD

Abroad (travel likely)Recruiting

Bucharest, Romania

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Systemic Lupus Erythematosus (Sle) · Primary Ovarian Insufficiency (Poi)

Abroad (travel likely)Recruiting

Bethesda, United States

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Systemic Lupus Erythematosus (SLE) · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia · Melbourne, Australia